The antitumor promoting activity of 2-himachalen-7-ol in two-stage mouse skin carcinogenesis test

Cedrus libani ssp. libani (Pinaceae) is a plant used in traditional medicine for the treatment of various diseases. 2-Himachalene-7-ol, previously isolated from the plant, possesses in vitro anticancer activity [1]. The present study investigates the chemopreventive effects of 2-himachalene-7-ol on...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Daher, CF (author)
مؤلفون آخرون: Iskandar, RJ (author), Dib El Jalbout, NO (author), Dwairi, VF (author), Zgheib, MC (author), Ibrahim, MC (author), Saad, JMC (author), Bakhos, PE (author), Chelala, NF (author), Daou, CP (author), Lteif, CS (author), Sawma Awad, LJ (author), Hakim, J. (author), Taleb, R. (author), El Sibai, M. (author), Mroueh, M. (author)
التنسيق: article
منشور في: 2016
الوصول للمادة أونلاين:http://hdl.handle.net/10725/7420
http://dx.doi.org/10.1055/s-0036-1596978
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0036-1596978
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513482125213696
author Daher, CF
author2 Iskandar, RJ
Dib El Jalbout, NO
Dwairi, VF
Zgheib, MC
Ibrahim, MC
Saad, JMC
Bakhos, PE
Chelala, NF
Daou, CP
Lteif, CS
Sawma Awad, LJ
Hakim, J.
Taleb, R.
El Sibai, M.
Mroueh, M.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Daher, CF
Iskandar, RJ
Dib El Jalbout, NO
Dwairi, VF
Zgheib, MC
Ibrahim, MC
Saad, JMC
Bakhos, PE
Chelala, NF
Daou, CP
Lteif, CS
Sawma Awad, LJ
Hakim, J.
Taleb, R.
El Sibai, M.
Mroueh, M.
author_role author
dc.creator.none.fl_str_mv Daher, CF
Iskandar, RJ
Dib El Jalbout, NO
Dwairi, VF
Zgheib, MC
Ibrahim, MC
Saad, JMC
Bakhos, PE
Chelala, NF
Daou, CP
Lteif, CS
Sawma Awad, LJ
Hakim, J.
Taleb, R.
El Sibai, M.
Mroueh, M.
dc.date.none.fl_str_mv 2016
2018-04-19T08:01:08Z
2018-04-19T08:01:08Z
2018-04-19
dc.identifier.none.fl_str_mv 1439-0221
http://hdl.handle.net/10725/7420
http://dx.doi.org/10.1055/s-0036-1596978
Daher, C. F., Iskandar, R. J., El Jalbout, N. D., Dwairi, V. F., Zgheib, M. C., Ibrahim, P. T., ... & Lteif, C. S. (2016). The antitumor promoting activity of 2-himachalen-7-ol in two-stage mouse skin carcinogenesis test. Planta Medica, 82(S 01), P994.
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0036-1596978
dc.language.none.fl_str_mv en
dc.relation.none.fl_str_mv Planta Medica
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.title.none.fl_str_mv The antitumor promoting activity of 2-himachalen-7-ol in two-stage mouse skin carcinogenesis test
dc.type.none.fl_str_mv Article
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description Cedrus libani ssp. libani (Pinaceae) is a plant used in traditional medicine for the treatment of various diseases. 2-Himachalene-7-ol, previously isolated from the plant, possesses in vitro anticancer activity [1]. The present study investigates the chemopreventive effects of 2-himachalene-7-ol on 7,12-dimethyl benz(a)anthracene (DMBA)/12-O-tetradecanoyl phorobol-13-acetate (TPA) skin tumorigenesis model in mice. The stem xylem was extracted with hexane and the obtained oil was subjected to silica gel chromatography to isolate 2-himachalen-7-ol. Papilloma were initiated on shaved dorsal skin using DMBA and promoted twice weekly using TPA for 20 weeks [2]. Animal groups were treated once weekly with 2-himachalen-7-ol via different routes: gavage (50 mg/kg), intraperitoneally (IP 10, 25, or 50 mg/kg) or topically (0.2mL of 0.5, 1 or 2.5%). Tumor yield, and volume were compared with those of non-treated control and cisplatinum-treated groups (IP 2.5 mg/kg). Liver and kidney toxicity as well as body weight changes were also investigated. Data were analysed using ANOVA. At week 16 all animal groups treated with either 2-himachalen-7-ol or cisplatinum had relatively less papilloma number (0 – 52%) and volume (30 – 66%; p < 0.05). At week 20 the number of papilloma was highest in the cisplatinum and lowest in the 2-himachalen-7-ol IP 10 mg/kg groups. Inhibition of papilloma volume was maximal in the 2-himachalen-7-ol IP 25, IP 50 and gavage (48 – 52%; p < 0.01) followed by IP 10 and topical 2.5% (43%: p < 0.05) then cisplatinum (28%; NS) groups. The least gain in body weight was observed with the cisplatinum group. Liver enzymes (ALP, ALT and AST) were not affected in all treated groups; however creatinine and urea levels were significantly higher (p < 0.05) in the cisplatinum group compared to control. In conclusion, 2-himachalen-7-ol has potent antitumor activity against DMBA/TPA skin carcinogenesis with relatively lower toxicity than commonly used chemotherapeutic drugs.
eu_rights_str_mv openAccess
format article
id LAURepo_2d6db901ee5a2b7c855d8f9eb8f721b8
identifier_str_mv 1439-0221
Daher, C. F., Iskandar, R. J., El Jalbout, N. D., Dwairi, V. F., Zgheib, M. C., Ibrahim, P. T., ... & Lteif, C. S. (2016). The antitumor promoting activity of 2-himachalen-7-ol in two-stage mouse skin carcinogenesis test. Planta Medica, 82(S 01), P994.
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/7420
publishDate 2016
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling The antitumor promoting activity of 2-himachalen-7-ol in two-stage mouse skin carcinogenesis testDaher, CFIskandar, RJDib El Jalbout, NODwairi, VFZgheib, MCIbrahim, MCSaad, JMCBakhos, PEChelala, NFDaou, CPLteif, CSSawma Awad, LJHakim, J.Taleb, R.El Sibai, M.Mroueh, M.Cedrus libani ssp. libani (Pinaceae) is a plant used in traditional medicine for the treatment of various diseases. 2-Himachalene-7-ol, previously isolated from the plant, possesses in vitro anticancer activity [1]. The present study investigates the chemopreventive effects of 2-himachalene-7-ol on 7,12-dimethyl benz(a)anthracene (DMBA)/12-O-tetradecanoyl phorobol-13-acetate (TPA) skin tumorigenesis model in mice. The stem xylem was extracted with hexane and the obtained oil was subjected to silica gel chromatography to isolate 2-himachalen-7-ol. Papilloma were initiated on shaved dorsal skin using DMBA and promoted twice weekly using TPA for 20 weeks [2]. Animal groups were treated once weekly with 2-himachalen-7-ol via different routes: gavage (50 mg/kg), intraperitoneally (IP 10, 25, or 50 mg/kg) or topically (0.2mL of 0.5, 1 or 2.5%). Tumor yield, and volume were compared with those of non-treated control and cisplatinum-treated groups (IP 2.5 mg/kg). Liver and kidney toxicity as well as body weight changes were also investigated. Data were analysed using ANOVA. At week 16 all animal groups treated with either 2-himachalen-7-ol or cisplatinum had relatively less papilloma number (0 – 52%) and volume (30 – 66%; p < 0.05). At week 20 the number of papilloma was highest in the cisplatinum and lowest in the 2-himachalen-7-ol IP 10 mg/kg groups. Inhibition of papilloma volume was maximal in the 2-himachalen-7-ol IP 25, IP 50 and gavage (48 – 52%; p < 0.01) followed by IP 10 and topical 2.5% (43%: p < 0.05) then cisplatinum (28%; NS) groups. The least gain in body weight was observed with the cisplatinum group. Liver enzymes (ALP, ALT and AST) were not affected in all treated groups; however creatinine and urea levels were significantly higher (p < 0.05) in the cisplatinum group compared to control. In conclusion, 2-himachalen-7-ol has potent antitumor activity against DMBA/TPA skin carcinogenesis with relatively lower toxicity than commonly used chemotherapeutic drugs.PublishedN/A2018-04-19T08:01:08Z2018-04-19T08:01:08Z20162018-04-19Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1439-0221http://hdl.handle.net/10725/7420http://dx.doi.org/10.1055/s-0036-1596978Daher, C. F., Iskandar, R. J., El Jalbout, N. D., Dwairi, V. F., Zgheib, M. C., Ibrahim, P. T., ... & Lteif, C. S. (2016). The antitumor promoting activity of 2-himachalen-7-ol in two-stage mouse skin carcinogenesis test. Planta Medica, 82(S 01), P994.http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.phphttps://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0036-1596978enPlanta Medicainfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/74202024-01-29T13:44:23Z
spellingShingle The antitumor promoting activity of 2-himachalen-7-ol in two-stage mouse skin carcinogenesis test
Daher, CF
status_str publishedVersion
title The antitumor promoting activity of 2-himachalen-7-ol in two-stage mouse skin carcinogenesis test
title_full The antitumor promoting activity of 2-himachalen-7-ol in two-stage mouse skin carcinogenesis test
title_fullStr The antitumor promoting activity of 2-himachalen-7-ol in two-stage mouse skin carcinogenesis test
title_full_unstemmed The antitumor promoting activity of 2-himachalen-7-ol in two-stage mouse skin carcinogenesis test
title_short The antitumor promoting activity of 2-himachalen-7-ol in two-stage mouse skin carcinogenesis test
title_sort The antitumor promoting activity of 2-himachalen-7-ol in two-stage mouse skin carcinogenesis test
url http://hdl.handle.net/10725/7420
http://dx.doi.org/10.1055/s-0036-1596978
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php
https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0036-1596978